290
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Immune profiling of a patient with relapsed HIV-Related and EBV-positive diffuse large B-Cell lymphoma treated with pembrolizumab

, , , , , & show all
Pages 1256-1260 | Received 12 Oct 2021, Accepted 21 Nov 2021, Published online: 16 Dec 2021
 

Acknowledgments

We acknowledge the support of these and other patients who consented to participate in lymphoma tissue banking within the Banque de cellules leucémiques du Québec (BCLQ) at the Jewish General Hospital. We thank the Jewish General Hospital Foundation and the Cole Foundation for supporting this lymphoma cell bank.

Disclosure statement

NJ has received consultancy fees from Merck, Roche, BMS and Abbvie. HD has been invited to sit on an Eli Lilly Canada SAB. SP has received consultancy fees from AAA Novartis.

Additional information

Funding

This work was supported by the Canadian Institutes of Health Research (PJT-155996); Canadian Cancer Society Research Institute (705478).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.